PROCALCITONIN BASED ANTIBIOTIC THERAPY: A REVIEW ON NEWER PERSPECTIVES

Abstract

Background: Procalcitonin (PCT) is an inflammation-induced biomarker that distinguishes bacterial and viral infections and guides antibiotic therapy. PCT's potential lies in enhancing patient outcomes and reducing antibiotic resistance. However, further research is required to validate its efficacy and safety.